Nearly half of cyber leaders claim they’ve hidden a material cybersecurity incident from their board IT Brew

FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or